Walter Fiedler

Antiangiogenic treatment with endostatin inhibits progression of AML in vivo

C. Bokemeyer, W. Fiedler, D. Hossfeld, 2005, Leukemia.

Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro

J. Wellbrock, L. Oliveira-Ferrer, T. Sturmheit, 2023, Frontiers in Immunology.

Phase I trial of SU14813 in patients with advanced solid malignancies.

G. Giaccone, C. Bokemeyer, W. Fiedler, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer.

G. Vohwinkel, W. Fiedler, C. Kugler, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.